SHERRY AULIN

Insider Reports History

Location
Burnaby
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SHERRY AULIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Financial Officer Common Shares 0 $0 $41.19 18 Dec 2024 Direct
Xenon Pharmaceuticals Inc. Chief Financial Officer Stock Option (Right to Buy) 6,000 18 Dec 2024 Direct

Insider Reports Filed by SHERRY AULIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 18 Dec 2024 8 -$770,999 4 Chief Financial Officer 19 Dec 2024, 18:57
XENE Xenon Pharmaceuticals Inc. 11 Mar 2024 1 $0 4 Chief Financial Officer 12 Mar 2024, 18:41
XENE Xenon Pharmaceuticals Inc. 10 Mar 2023 1 $0 4 Chief Financial Officer 14 Mar 2023, 16:25
XENE Xenon Pharmaceuticals Inc. 02 Sep 2022 12 -$607,708 4 Chief Financial Officer 07 Sep 2022, 16:26
XENE Xenon Pharmaceuticals Inc. 10 Mar 2022 1 $0 4 Chief Financial Officer 14 Mar 2022, 16:11
XENE Xenon Pharmaceuticals Inc. 03 Jun 2021 1 $0 4 Chief Financial Officer 03 Jun 2021, 16:42
XENE Xenon Pharmaceuticals Inc. 03 Jun 2021 0 $0 3 Chief Financial Officer 03 Jun 2021, 16:35